Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardization of coding definitions for sickle cell disease complications: A systematic literature review.

Pharmacoepidemiology and drug safety·2024
Same author

Editorial: Stress erythropoiesis.

Frontiers in physiology·2023
Same author

Development and Validation of the Patient/Caregiver Reported Hydroxyurea Evaluation of Adherence for Life (HEAL) Scale.

Patient preference and adherence·2022
Same author

Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center.

Pediatric blood & cancer·2022
Same author

No child left behind: Building a comprehensive sickle cell disease care oasis in the Lake County, Indiana care desert.

Pediatric blood & cancer·2022
Same author

Use of dual-electron probes reveals the role of ferritin as an iron depot in <i>ex vivo</i> erythropoiesis.

iScience·2021

Related Experiment Video

Updated: May 23, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Sickle cell disease in children.

Emily Riehm Meier1, Jeffery L Miller

  • 1Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Drugs
|April 24, 2012
PubMed
Summary

Newborn screening for sickle cell disease (SCD) and early interventions like penicillin and hydroxyurea have improved survival and reduced complications in children. Genetic therapies offer future prevention and cures for SCD.

Area of Science:

  • Pediatrics
  • Hematology
  • Genetics

Background:

  • Newborn screening for sickle cell disease (SCD) is now universal in the US.
  • Early identification improves survival by preventing sepsis with prophylactic penicillin.
  • Key complications in pediatric SCD include stroke, painful crises, and acute chest syndrome.

Purpose of the Study:

  • To review clinical manifestations and therapeutic strategies for pediatric SCD.
  • To discuss the evolving role of gene-focused prevention and therapy for SCD.

Main Methods:

  • Review of existing literature on pediatric sickle cell disease management.
  • Analysis of current and emerging therapeutic strategies, including genetic research.

Main Results:

More Related Videos

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

Related Experiment Videos

Last Updated: May 23, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

  • Universal newborn screening and early penicillin prophylaxis significantly reduce sepsis-related mortality.
  • Transcranial Doppler screening and chronic transfusions decrease stroke risk from 10% to 1%.
  • Hydroxyurea therapy reduces painful crises, acute chest syndromes, and transfusion needs.

Conclusions:

  • Current management strategies have markedly improved outcomes for children with SCD.
  • Ongoing genetic research holds promise for the ultimate prevention and cure of SCD.
  • Focus is shifting towards long-term prevention and curative gene-based therapies for SCD.